To advance
#PrecisionOncology
it is absolutely imperative to publish „negative“ results so that we can learn from each other.
➡️
@IntJCanc
🇦🇺✚🇳🇱 data on limited activity of CDK4/6❌ in
#cancer
#patients
w CDK4/6 alts
#PrecisionMedicine
@OncoAlert
🚨
4
25
70
Replies
@BenWestphalen
@IntJCanc
@OncoAlert
Absolutely needed so we can move forward, negative trial doesn't equal bad thing
Every question that got answered with Positive or Negative is always helpful. Thank you so much for sharing this 🙏
0
0
2
0
0
3
@BenWestphalen
@EileenMOReilly
@IntJCanc
@OncoAlert
Interesting paper even if with small numbers on the importance of correct precision therapy…
0
0
2